Similar articles

• Update on screening breast MRI in high-risk women.

  Boetes C. Boetes C. Magn Reson Imaging Clin N Am. 2010 May;18(2):241-7, viii. doi: 10.1016/j.mric.2010.02.003. Magn Reson Imaging Clin N Am. 2010. PMID: 20494309 Review.
• Breast magnetic resonance image screening and ductal lavage in women at high genetic risk for breast carcinoma.

  Hartman AR, Daniel BL, Kurian AW, Mills MA, Nowels KW, Dirbas FM, Kingham KE, Chun NM, Herfkens RJ, Ford JM, Plevritis SK. Hartman AR, et al. Cancer. 2004 Feb 1;100(3):479-89. doi: 10.1002/cncr.11926. Cancer. 2004. PMID: 14745863 Clinical Trial.
• MRI in breast cancer management: potential for benefit and harm.

  Jatoi I. Jatoi I. Int J Fertil Womens Med. 2005 Nov-Dec;50(6):281-4. Int J Fertil Womens Med. 2005. PMID: 16526420 Review.
• High-risk screening: multi-modality surveillance of women at high risk for breast cancer (proven or suspected carriers of a breast cancer susceptibility gene).

  Kuhl CK. Kuhl CK. J Exp Clin Cancer Res. 2002 Sep;21(3 Suppl):103-6. J Exp Clin Cancer Res. 2002. PMID: 12585663
• The UK national study of magnetic resonance imaging as a method of screening for breast cancer (MARIBS).

  Leach MO, Eeles RA, Turnbull LW, Dixon AK, Brown J, Hoff RJ, Coulthard A, Dixon JM, Easton DF, Evans DG, Gilbert FJ, Hawnaur J, Hayes C, Kessar P, Lakhani S, Liney G, Moss SM, Padhani AP, Pointon LJ, Sydenham M, Walker LG, Warren RM, Haites NE, Morrison P, Cole T, Rayter Z, Donaldson A, Shere M, Rankin J, Goudie D, Steel CM, Davidson R, Chu C, Ellis I, Mackay J, Hodgson SV, Homfray T, Douglas F, Quarrell OW, Eccles DM, Gilbert FG, Crothers G, Walker CP, Jones A, Slack N, Britton P, Sheppard DG, Walsh J, Whitehouse G, Teh W, Rankin S, Boggis C, Potterton J, McLean L, Gordon PA, Rubin C; Magnetic Resonance Imaging as a Method of Screening for Breast Cancer Advisory Group. Leach MO, et al. J Exp Clin Cancer Res. 2002 Sep;21(3 Suppl):107-14. J Exp Clin Cancer Res. 2002. PMID: 12585664